USPTO serial 79346056
KLARIFY
Reviewed by CopyMark Law Group
Status 802
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRUCK, ROBERT J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KLARIFY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C1101 K Street, N.W., 10th FloorWashington, DC 20005United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Testing apparatus for medical purposes, namely, immunochemical testing apparatus for medical use in relation to allergy and asthma; spirometers, namely, incentive spirometers for medical use; apparatus for carrying-out diagnostic tests for medical purposes, namely, medical diagnostic apparatus for testing for allergy and asthma; medical devices for self or home testing for allergy, namely, medical diagnostic apparatus for testing for allergies; electric devices for analyzing the condition of allergy and asthma patients, namely, medical diagnostic apparatus for detecting allergies and asthma; inhalers for medical or therapeutic use in relation to allergy and asthma; nebulizers for medical use in relation to allergy and asthma; nasal filters for medical purposes for allergy and asthma patients; none of the aforesaid goods for use in the cardiovascular field nor for use in continence management | ACTIVE | — |
| 035 | Compilation and collection into a computer database of scientific and pharmaceutical data relating to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; wholesale and retail store services, also online and via an e-commerce platform, featuring pharmaceutical and veterinary preparations for immunotherapeutic purposes, pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; wholesale and retail store services, also online and via an e-commerce platform, featuring diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing materials for medical use in the field of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy, eye drops, nose drops, nasal sprays; wholesale and retail store services, also online and via an e-commerce platform, featuring pharmaceutical preparations for inhalers, pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; wholesale and retail store services, also online and via an e-commerce platform, featuring dietary and nutritional supplements for humans and for animals, food supplements for humans and for animals, food supplements in the form of peanut powder for the prevention of allergies in humans or animals, probiotic supplements for humans and animals, probiotic preparations for medical and veterinary use, also online and via an e-commerce platform, in relation to infant formula, namely, lactose free infant formula and hydrolyzed milk formula, additives for infant formula to prevent the development of allergies, food for babies, diagnostic testing materials for medical use, allergy and asthma testing kits, scientific, checking and supervision, life-saving and teaching apparatus and instruments, computer software, particularly computer software for medical use; wholesale and retail store services, also online and via an e-commerce platform, featuring diagnostic apparatus for testing food, namely, for mould detection, sensors for detecting and analyzing the presence of chemicals, toxins, mould and allergens in food, food components and food products, downloadable electronic publications in the nature of magazines and periodicals, electronic magazines and periodicals, online questionnaires; wholesale and retail store services, also online and via an e-commerce platform, featuring medical apparatus and instruments, testing apparatus for medical purposes, spirometers, namely, incentive spirometers for medical use; wholesale and retail store services, also online and via an e-commerce platform, featuring apparatus for carrying-out diagnostic tests for medical purposes, medical devices for self or home testing for allergy, electric devices for analysing the condition of allergy and asthma patients, inhalers for medical or therapeutic use, nebulizers for medical use, nasal filters; wholesale and retail store services, also online and via an e-commerce platform, featuring printed matter, instructional and teaching materials, magazines and periodicals, printed questionnaires; wholesale and retail store services, also online and via an e-commerce platform, featuring bed linen, edible oils derived from fish; all the aforesaid goods relating to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 12, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 12, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 1, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 4, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 29, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 12, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 17, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jun 17, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Mar 8, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 3, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 8, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 8, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 8, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 1, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 5, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 1, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |